Search

Spahn M

Stroma transcriptomic and proteomic profile of prostate cancer metastasis xenograft models reveals conservation of bone microenvironment signatures
Patient-derived xenografts and organoids model therapy response in prostate cancer
Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification
miR-221 Augments TRAIL-Mediated Apoptosis in Prostate Cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and PIK3R1
miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo
Emerging aspects of microRNA interaction with TMPRSS2-ERG and endocrine therapy
ALK1Fc Suppresses the Human Prostate Cancer Growth in in Vitro and in Vivo Preclinical Models